Metallothionein immunoexpression in non-syndromic and syndromic keratocystic odontogenic tumour

Med Oral Patol Oral Cir Bucal. 2015 Jul 1;20(4):e408-12. doi: 10.4317/medoral.20418.

Abstract

Background: To compare the metallothionein (MT) immunoexpression in non-syndromic and syndromic keratocystic odontogenic tumour (KOT), to correlate MT with cellular proliferation, and to evaluate the influence of inflammation in MT.

Study design: Fourteen cases of KOT were submitted to immunohistochemistry for MT and Ki-67 analysis. The lesions were grouped according to their grade of inflammation, and statistical analysis was performed.

Results: MT was higher in non-syndromic KOT than in syndromic KOT (p<0.05). No statistical difference in Ki-67 could be identified; however, an inverse correlation was observed between MT and Ki-67 in both lesions. When analysing inflammation, non-syndromic KOT showed no differences in either MT or Ki-67.

Conclusions: The MT immunophenotype of syndromic KOT was different from non-syndromic KOT. MT might not be involved in the proliferation control of both KOT. MT and Ki-67 immunoexpressions proved to be unaffected by inflammation in non-syndromic KOT.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Immunohistochemistry
  • Ki-67 Antigen / biosynthesis
  • Ki-67 Antigen / immunology
  • Metallothionein / biosynthesis
  • Metallothionein / immunology*
  • Odontogenic Cysts / immunology*
  • Odontogenic Cysts / metabolism
  • Odontogenic Cysts / pathology
  • Syndrome

Substances

  • Ki-67 Antigen
  • Metallothionein